CAS # 33419-42-0
USP / EP Oncology Grade (MW 588.6 g/mol)
Etoposide Topoisomerase II Inhibitor
Etoposide is a podophyllotoxin-derived Topoisomerase II inhibitor (C29H32O13, CAS 33419-42-0). Widely used in combination chemotherapy for Small Cell Lung Cancer (SCLC) and refractory testicular cancer.
Assay / Purity
98.0% - 102.0% (C29H32O13)
Physical Appearance
White to Off-White Crystalline Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Etoposide Topoisomerase II Inhibitor
CAS Registry Number
33419-42-0
Standard Grade
USP / EP Oncology Grade (MW 588.6 g/mol)
Assay / Purity
98.0% - 102.0% (C29H32O13)
Appearance
White to Off-White Crystalline Powder
Formulation & Industry Applications
Intravenous Chemotherapy
Oral Capsules
Combination SCLC Regimens
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: